›› 2020, Vol. 40 ›› Issue (8): 728-730.

• 临床研究 • 上一篇    下一篇

医用射线防护喷剂防治放射性口腔黏膜炎的临床观察

王楠   

  1. 大连市中心医院
  • 收稿日期:2019-05-21 修回日期:2019-08-10 出版日期:2020-08-29 发布日期:2020-08-28
  • 通讯作者: 王楠 E-mail:22101173@qq.com

Clinical Observation of Medical Radiation Protection Spray in Prevention and Treatment of Radioactive Oral Mucositis

Wang nan   

  • Received:2019-05-21 Revised:2019-08-10 Online:2020-08-29 Published:2020-08-28
  • Contact: Wang nan E-mail:22101173@qq.com

摘要: 目的 观察医用射线防护喷剂(伯格曼)对头颈部肿瘤放射性口腔黏膜炎的防治效果。方法:回顾分析头颈部恶性肿瘤放疗患者82例,其中42例仅给予康复新液口服及漱口处理的为对照组,40例在对照组基础上同时给予伯格曼喷于口腔黏膜表面的为试验组。两组均采用的常规分割调强放疗,肿瘤临床靶区(CTV)剂量为65~70 Gy/36次。结果:两组患者放疗时均发生了急性口腔黏膜炎,试验组患者77.5%放射性口腔黏膜炎出现在放射剂量≥40Gy,而对照组69.05%出现在40 Gy之前(P<0.05);试验组口腔黏膜炎严重程度(2、3级放射性口腔黏膜炎的发生率)明显低于对照组(P<0.01);放疗前后试验组患者的体重减轻程度明显低于对照组,有统计学意义(P<0.05)。结论:预防性应用医用射线防护喷剂(伯格曼)可以推迟急性放射性口腔黏膜炎的发生,减轻口腔黏膜炎的严重程度,减少放疗期间体重的下降,防治口腔黏膜炎安全有效。

关键词: 头颈部肿瘤, 伯格曼, 放射性口腔黏膜炎

Abstract: Objective:To observe the preventive and therapeutic effect of medical radiation protective spray (Bergman) on radiation-induced oral mucositis in head and neck tumors.Methods:A retrospective analysis was made of 82 patients with head and neck malignant tumors treated with radiotherapy, 42 of whom were treated with Kangfuxin liquid orally and mouthwash only as control group, and 40 cases were treated with Bergman spraying on oral mucosal surface as experimental group on the basis of control group. Both groups were treated with conventional fractionated intensity modulated radiation therapy. The dose of CTV was 65-70 Gy/36f.Result: Acute oral mucositis occurred in both groups during radiotherapy. 77.5% of the patients in the experimental group were exposed to radiation dose (≥40 Gy), while 69.05% in the control group were exposed to radiation dose (<40Gy) (P<0.05); the severity of oral mucositis in the experimental group (incidence of grade 2 and 3 radioactive oral mucositis) was significantly lower than that in the control group (P < 0.01); the body mass of the experimental group before and after radiotherapy was significantly lower than that of the control group (P < 0.01). The degree of weight reduction was significantly lower than that of the control group (P < 0.05).Conclusion: Preventive application of medical radiation protective spray (Bergman) can delay the occurrence of acute radiation oral mucositis, reduce the severity of oral mucositis, reduce the weight loss during radiotherapy, and prevent and treat oral mucositis safely and effectively.

Key words: Head and neck neoplasms, Bergman, Radioactive oral mucositis

中图分类号: